BARBANTI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 6.981
NA - Nord America 1.685
AS - Asia 314
AF - Africa 3
OC - Oceania 3
SA - Sud America 3
Totale 8.989
Nazione #
IE - Irlanda 5.277
US - Stati Uniti d'America 1.680
GB - Regno Unito 814
CH - Svizzera 405
FI - Finlandia 299
SG - Singapore 183
DE - Germania 86
HK - Hong Kong 61
IT - Italia 52
CZ - Repubblica Ceca 32
KR - Corea 25
CN - Cina 20
NL - Olanda 9
CA - Canada 5
TR - Turchia 5
IN - India 4
TW - Taiwan 4
AU - Australia 3
BE - Belgio 3
BR - Brasile 3
IR - Iran 3
UG - Uganda 3
FR - Francia 2
IL - Israele 2
NP - Nepal 2
PK - Pakistan 2
TH - Thailandia 2
ES - Italia 1
JP - Giappone 1
RU - Federazione Russa 1
Totale 8.989
Città #
Dublin 5.240
London 808
Ashburn 772
Boardman 407
Zurich 405
Helsinki 299
Washington 197
Singapore 92
Hong Kong 60
Seoul 25
Brno 21
Seattle 21
Chicago 20
Munich 20
Los Angeles 17
Falkenstein 12
Milan 11
Olomouc 11
Amsterdam 8
Shanghai 8
Tappahannock 8
Catania 6
Genoa 5
Ottawa 5
Rome 5
Berlin 3
Brasília 3
Brussels 3
Kampala 3
Melbourne 3
Sivas 3
Taipei 3
Turin 3
Aci Sant'Antonio 2
Bangkok 2
Guildford 2
Hadera 2
Karachi 2
Mantova 2
Nuremberg 2
Pollenza 2
Spring 2
Surat 2
Tehran 2
Vittoria 2
West Jordan 2
Bardhaman 1
Bochum 1
Brescia 1
Fiorenzuola d'Arda 1
Frankfurt am Main 1
Guangzhou 1
Karlsruhe 1
Kathmandu 1
Magione 1
Mesa 1
New York 1
Palermo 1
Sale Marasino 1
San Severo 1
Santa Clara 1
Segovia 1
Stockton-on-Tees 1
Taichung 1
Tolentino 1
Waldshut-Tiengen 1
Xuzhou 1
Yokohama 1
Totale 8.555
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 92
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 63
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 55
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 53
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 49
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 48
The Helio transcatheter aortic dock for patients with aortic regurgitation 45
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 45
Early discharge after transfemoral transcatheter aortic valve implantation 45
Early detection of transcatheter heart valve dysfunction 44
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 44
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era: A “Die-Hard” Procedure 44
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 44
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 44
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 43
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 43
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 43
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 43
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 43
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 42
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 42
Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a comparison and evaluation of current findings 42
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 41
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 41
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 41
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 40
Cerebral embolization during transcatheter aortic valve implantation 40
Early Outcomes of the Evolut R Transcatheter Aortic Valve: A New Technology Between Achieved Goals and Desirable Improvements 40
Managing complications after transcatheter aortic valve implantation 39
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 39
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 39
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 39
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 39
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 39
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 39
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 39
Transcatheter mitral valve repair: a brief review 38
Bioprosthetic valves for transcatheter aortic valve replacement 38
Feasibility and predictors of early discharge after percutaneous edge-to-edge mitral valve repair 38
The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation 38
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 38
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 38
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes 38
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 37
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 37
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 37
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis 37
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 37
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 37
Protesi Percutanee Aortiche: Le indicazioni si allargano 37
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 37
Avoiding Coronary Occlusion and Root Rupture in TAVI – The Role of Pre-procedural Imaging and Prosthesis Selection 37
Balloon-Expandable Valve for Treatment of Self-Expanding Supra-Annular Valve Failure 37
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 36
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 36
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 36
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 36
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 36
Plug-Based Endovascular Closure of Large Bore Aortofemoral Graft Arteriotomy for Transcatheter Aortic Valve Replacement 36
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 36
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 36
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 36
Sinus of Valsalva Sequestration Following Transcatheter-Based Management of ACURATE neo2 Valve Embolization 36
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 36
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 36
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 36
Transcatheter aortic valve replacement in bicuspid aortic valve disease 36
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 36
Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes 36
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 36
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 35
How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures 35
How true delivery profile diminution reduces vascular access challenges and complications 35
Reduction of mitral valve regurgitation with Mitraclip® percutaneous system 35
Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients With Failing Bioprosthetic Aortic Valves: Mid-term Outcomes From the Italian CoreValve Clinical Service Project 35
Update on percutaneous mitral valve therapy: clinical results and real life experience 35
Response to Letter by Piriou et al Regarding Article, "Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation" 35
Management of severe stenosis controversies and promises 35
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion 35
Transcatheter mitral valve implantation: CardiAQ 35
Transcatheter aortic valve implantation: what has been done and what is going to be done 35
Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients 35
Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation 35
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 34
Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves 34
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 34
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 34
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 34
The Learning Curve and Annual Procedure Volume Standards for Optimum Outcomes of Transcatheter Aortic Valve Replacement: Findings From an International Registry 34
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 34
Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study 34
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 33
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 33
TAVR and Left Main Stenting: Can 2 Giants Live in Harmony in a Small Room? 33
Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation 33
Optimisation of TAVI: is it mature enough to be defined as a PCI-like procedure? 33
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 33
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 33
Transcatheter Aortic Valve Implantation Under Angiographic Guidance With and Without Adjunctive Transesophageal Echocardiography 33
Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis Patients Undergoing Chronic Dialysis 33
Totale 3.883
Categoria #
all - tutte 55.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/2025419 419 0 0 0 0 0 0 0 0 0 0 0
Totale 9.379